These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 30745801)
1. MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation. Huang YH; Kuo HC; Yang YL; Wang FS Int J Med Sci; 2019; 16(2):212-220. PubMed ID: 30745801 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-29a Alleviates Bile Duct Ligation Exacerbation of Hepatic Fibrosis in Mice through Epigenetic Control of Methyltransferases. Yang YL; Wang FS; Li SC; Tiao MM; Huang YH Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106784 [TBL] [Abstract][Full Text] [Related]
3. Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4. Huang YH; Tiao MM; Huang LT; Chuang JH; Kuo KC; Yang YL; Wang FS PLoS One; 2015; 10(8):e0136453. PubMed ID: 26305546 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-29a mitigation of toll-like receptor 2 and 4 signaling and alleviation of obstructive jaundice-induced fibrosis in mice. Lin YC; Wang FS; Yang YL; Chuang YT; Huang YH Biochem Biophys Res Commun; 2018 Feb; 496(3):880-886. PubMed ID: 29366780 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-29a mitigation of endoplasmic reticulum and autophagy aberrance counteracts in obstructive jaundice-induced fibrosis in mice. Huang YH; Yang YL; Huang FC; Tiao MM; Lin YC; Tsai MH; Wang FS Exp Biol Med (Maywood); 2018 Jan; 243(1):13-21. PubMed ID: 29105510 [TBL] [Abstract][Full Text] [Related]
6. Microarray Study of Pathway Analysis Expression Profile Associated with MicroRNA-29a with Regard to Murine Cholestatic Liver Injuries. Li SC; Wang FS; Yang YL; Tiao MM; Chuang JH; Huang YH Int J Mol Sci; 2016 Mar; 17(3):324. PubMed ID: 26938532 [TBL] [Abstract][Full Text] [Related]
7. Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha. Yang YL; Wang FS; Lin HY; Huang YH Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455716 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway. Tiao MM; Wang FS; Huang LT; Chuang JH; Kuo HC; Yang YL; Huang YH Apoptosis; 2014 Jan; 19(1):30-41. PubMed ID: 24052410 [TBL] [Abstract][Full Text] [Related]
9. Hydroxysafflor yellow A exerts anti-fibrotic and anti-angiogenic effects through miR-29a-3p/PDGFRB axis in liver fibrosis. Xue X; Li Y; Zhang S; Yao Y; Peng C; Li Y Phytomedicine; 2024 Sep; 132():155830. PubMed ID: 38959553 [TBL] [Abstract][Full Text] [Related]
10. CXCL6-EGFR-induced Kupffer cells secrete TGF-β1 promoting hepatic stellate cell activation via the SMAD2/BRD4/C-MYC/EZH2 pathway in liver fibrosis. Cai X; Li Z; Zhang Q; Qu Y; Xu M; Wan X; Lu L J Cell Mol Med; 2018 Oct; 22(10):5050-5061. PubMed ID: 30106235 [TBL] [Abstract][Full Text] [Related]
11. EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ. Du Z; Liu M; Wang Z; Lin Z; Feng Y; Tian D; Xia L Cell Prolif; 2021 Jul; 54(7):e13072. PubMed ID: 34031939 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice. Yang YL; Kuo HC; Wang FS; Huang YH Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30917489 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-29a-3p prevents Schistosoma japonicum-induced liver fibrosis by targeting Roundabout homolog 1 in hepatic stellate cells. Kong H; Song Q; Hu W; Guo S; Xiang D; Huang S; Xu X; He J; Pan L; Tao R; Yu H; Huang J Parasit Vectors; 2023 Jun; 16(1):184. PubMed ID: 37280619 [TBL] [Abstract][Full Text] [Related]
14. MiR-22-3p and miR-29a-3p synergistically inhibit hepatic stellate cell activation by targeting AKT3. Wang Y; Zhang R; Li J; Han X; Lu H; Su J; Liu Y; Tian X; Wang M; Xiong Y; Lan T; Zhang G; Liu Z Exp Biol Med (Maywood); 2022 Oct; 247(19):1712-1731. PubMed ID: 35833537 [TBL] [Abstract][Full Text] [Related]
15. Wnt Pathway Stabilizes MeCP2 Protein to Repress PPAR-γ in Activation of Hepatic Stellate Cells. Kweon SM; Chi F; Higashiyama R; Lai K; Tsukamoto H PLoS One; 2016; 11(5):e0156111. PubMed ID: 27214381 [TBL] [Abstract][Full Text] [Related]
16. Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice. Kennedy LL; Meng F; Venter JK; Zhou T; Karstens WA; Hargrove LA; Wu N; Kyritsi K; Greene J; Invernizzi P; Bernuzzi F; Glaser SS; Francis HL; Alpini G Lab Invest; 2016 Dec; 96(12):1256-1267. PubMed ID: 27775690 [TBL] [Abstract][Full Text] [Related]
17. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis. Martin-Mateos R; De Assuncao TM; Arab JP; Jalan-Sakrikar N; Yaqoob U; Greuter T; Verma VK; Mathison AJ; Cao S; Lomberk G; Mathurin P; Urrutia R; Huebert RC; Shah VH Cell Mol Gastroenterol Hepatol; 2019; 7(1):197-209. PubMed ID: 30539787 [TBL] [Abstract][Full Text] [Related]
18. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis. Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480 [No Abstract] [Full Text] [Related]
19. JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis. Xie L; Chen H; Zhang L; Ma Y; Zhou Y; Yang YY; Liu C; Wang YL; Yan YJ; Ding J; Teng X; Yang Q; Liu XP; Wu J Clin Mol Hepatol; 2024 Apr; 30(2):206-224. PubMed ID: 38190829 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice. Lin HY; Wang FS; Yang YL; Huang YH Cells; 2019 Oct; 8(10):. PubMed ID: 31652636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]